RxDoctor Payments Data

Angela Primovic, APRN

Family · Coshocton, OHNPI 1164026258

Payments from drug & device makers

$721in general payments, 2019–2025

Across 39 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$145
  • AstraZeneca$129
  • Biohaven Pharmaceutical Holding Company Ltd.$94
  • Exact Sciences$70
  • GSK$53
  • Merck$35
  • plus $195 from 9 others

What the payments were for

  • Food & beverage$721100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$721 in reported general payments places this provider in the 65th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$7,020
Medicare patients
80
Services billed
181

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin39$40,999
TrulicityDulaglutide27$28,933
EliquisApixaban31$25,834
Spiriva RespimatTiotropium Bromide17$12,761
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$12,316
OzempicSemaglutide12$11,491
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,216
Breo ElliptaFluticasone/Vilanterol13$5,077
Albuterol Sulfate HfaAlbuterol Sulfate162$3,911
SymbicortBudesonide/Formoterol Fumarate11$2,509
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,690
Omeprazole141$1,296
Levothyroxine Sodium146$1,089
Rosuvastatin Calcium48$861
Atorvastatin Calcium140$840

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$27$25,83431 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$53$22,60838 claims
Novo NordiskOzempic$28$11,49112 claims
AstraZenecaSymbicort$129$2,50911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,812 family providers in Ohio.

Other family in Coshocton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →